Can We Predict Individual Concentrations of Tacrolimus After Liver Transplantation? Application and Tweaking of a Published Population Pharmacokinetic Model in Clinical Practice

Autor: José Ursic-Bedoya, Lucy Meunier, Sonia Khier, Julien Fraisse, Anna H-X. P. Chan Kwong, Marie-Astrid Decrocq-Rudler

Publikováno v: Therapeutic Drug Monitoring
Therapeutic Drug Monitoring, 2021, 43 (4), pp.490-498. ⟨10.1097/FTD.0000000000000867⟩

International audience; Background: Various population pharmacokinetic models have been developed to describe the pharmacokinetics of tacrolimus in adult liver transplantation. However, their extrapolated predictive performance remains unclear in cli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0432299ee4cee82f0b5eb1ac2101213f
https://pubmed.ncbi.nlm.nih.gov/33560099

Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants

Autor: Luger, Thomas, Boguniewicz, Mark, Carr, Warner, Cork, Michael, Deleuran, Mette, Eichenfield, Lawrence, Eigenmann, Philippe, Fölster‐Holst, Regina, Gelmetti, Carlo, Gollnick, Harald, Hamelmann, Eckard, Hebert, Adelaide, Muraro, Antonella, Oranje, Arnold, Paller, Amy, Paul, Carle, Puig, Luis, Ring, Johannes, Siegfried, Elaine, Spergel, Jonathan, Stingl, Georg, Taieb, Alain, Torrelo, Antonio, Werfel, Thomas, Wahn, Ulrich

Publikováno v: Pediatric Allergy and Immunology
Pediatric Allergy and Immunology, Wiley, 2015, 26 (4), pp.306-315. ⟨10.1111/pai.12331⟩

International audience; Atopic dermatitis (AD) is a distressing dermatological disease, which is highly prevalent during infancy, can persist into later life and requires long-term management with anti-inflammatory compounds. The introduction of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2b1cf90fc23706e49236115a2ed370d8
https://hal-univ-tlse3.archives-ouvertes.fr/hal-03482750

Thymoglobulin Induction and Sirolimus Versus Tacrolimus in Kidney Transplant Recipients Receiving Mycophenolate Mofetil and Steroids

Autor: Jean-Marc Chalopin, Yves Vanrenterghem, Lionel Rostaing, Bernard Bourbigot, François Berthoux, Daniel Abramovicz, Bernard Charpentier, Nicole Lefrançois, Michel Delahousse, Elisabeth Cassuto, Gérard Rifle, Denis Glotz, Philippe Lang

Publikováno v: Transplantation
Transplantation, Lippincott, Williams & Wilkins, 2010, 89 (12), pp.1511-7. ⟨10.1097/TP.0b013e3181db09e4⟩
Transplantation, 2010, 89 (12), pp.1511-7. ⟨10.1097/TP.0b013e3181db09e4⟩

International audience; BACKGROUND: To define the role of mammalian target of rapamycin inhibitors in kidney transplantation, we compared efficacy and safety of two immunosuppressive regimens-a calcineurin inhibitor-free regimen with depletive induct

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd97b697c093d2cc88384248efea301e
https://doi.org/10.1097/tp.0b013e3181db09e4

In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function

Autor: Olivier Moralès, Nadira Delhem, Yvan de Launoit, Véronique Pancré, Céline Miroux, Filomena Conti, Khaldoun Ghazal, Samia Ben Othman

Publikováno v: Transplantation
Transplantation, 2012, 94 (2), pp.123-31. ⟨10.1097/TP.0b013e3182590d8f⟩
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-31. 〈10.1097/TP.0b013e3182590d8f〉
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-31. ⟨10.1097/TP.0b013e3182590d8f⟩
Transplantation, Lippincott, Williams & Wilkins, 2012, 94 (2), pp.123-131. ⟨10.1097/TP.0b013e3182590d8f⟩

International audience; BACKGROUND: Liver transplantation is the treatment of end-stage liver diseases, including hepatitis C. Immunosuppression prevents graft rejection but seems to accelerate the recurrence of hepatitis C. Regulatory T cells (Tregs

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1369a0a3992dac7abd57361a290b4e4c
https://hal.science/hal-00785885

Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: a randomized, open-label trial

Autor: Pavel Trunecka, Nasrullah Undre, Bruno Gridelli, Andrés Valdivieso, Stephen V. Lynch, Evaristo Varo, Lutz Fischer, André Roy, Karim Boudjema, Carmen Karpf, Daniel Seehofer, Alessandro Vitale, Bo Göran Ericzon, Didier Samuel

Publikováno v: Liver Transplantation
Liver Transplantation, Wiley, 2011, 17 (2), pp.167-77. ⟨10.1002/lt.22211⟩
Liver Transplantation, 2011, 17 (2), pp.167-77. ⟨10.1002/lt.22211⟩
Liver Transplantation, Wiley, 2011, 17 (2), pp.167-77. 〈10.1002/lt.22211〉

International audience; Tacrolimus, a cornerstone immunosuppressant, is available as a twice-daily formulation (tacrolimus bid). A once-daily prolonged-release formulation (tacrolimus qd) has been developed. This 6-week, randomized, phase 2, multicen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf0e8a57debc4f7674667e38258887cd
https://hal.archives-ouvertes.fr/hal-00739522